Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 Jul;26(4):775-83.
doi: 10.1017/s003329170003779x.

A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system

Affiliations
Clinical Trial

A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system

J Williams et al. Psychol Med. 1996 Jul.

Abstract

We examined the reliability of the OPCRIT system from ratings produced by 30 USA and European clinicians involved in molecular genetic research. The OPCRIT system facilitates a polydiagnostic approach to research on severe psychiatric disorders. OPCRIT comprises a 90-item checklist of signs and symptoms and a suite of computer programs, which together generate diagnoses according to the operational criteria of 12 major classificatory systems (e.g. DSM-III, DSM-III-R, RDC, ICD-10). Thirty summaries of actual cases ranging in signs and symptoms, taken from independent sources, were rated by participants from research centres across Europe and the USA using the OPCRIT system. Each rating was then compared to a standard rating using a kappa statistic. Good levels of reliability were observed within all classifications (e.g. DSM-III-R, kappa = 0.73, RDC, kappa = 0.71; ICD-10, kappa = 0.70) and a similar pattern of ratings was found in both the European and USA samples. We conclude that the OPCRIT system, is both flexible and practicable retaining the 'top-down' advantage of operational definitions as well as the 'bottom-up' potential offered by well defined signs, symptoms and other component items. Within the limitations of an international, multicentre design this study shows that the OPCRIT system affords good reliability with raters from a variety of geographical and theoretical backgrounds.

PubMed Disclaimer

Similar articles

Cited by

  • Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family history.
    Bergen SE, O'Dushlaine CT, Lee PH, Fanous AH, Ruderfer DM, Ripke S; International Schizophrenia Consortium, Swedish Schizophrenia Consortium; Sullivan PF, Smoller JW, Purcell SM, Corvin A. Bergen SE, et al. Schizophr Res. 2014 Apr;154(1-3):48-53. doi: 10.1016/j.schres.2014.01.030. Epub 2014 Feb 26. Schizophr Res. 2014. PMID: 24581549 Free PMC article.
  • Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.
    Ferraro L, La Cascia C, Quattrone D, Sideli L, Matranga D, Capuccio V, Tripoli G, Gayer-Anderson C, Morgan C, Sami MB, Sham P, de Haan L, Velthorst E, Jongsma HE, Kirkbride JB, Rutten BPF, Richards AL, Roldan L, Arango C, Bernardo M, Bobes J, Sanjuan J, Santos JL, Arrojo M, Tarricone I, Tortelli A, Szöke A, Del-Ben CM, Selten JP, Lynskey M, Jones PB, Van Os J, La Barbera D; WP2 EU-GEI GROUP; Murray RM, Di Forti M. Ferraro L, et al. Schizophr Bull. 2020 Apr 10;46(3):517-529. doi: 10.1093/schbul/sbz077. Schizophr Bull. 2020. PMID: 31361020 Free PMC article.
  • The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.
    Spinazzola E, Quattrone D, Rodriguez V, Trotta G, Alameda L, Tripoli G, Gayer-Anderson C, Freeman TP, Johnson EC, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, D'Andrea G, Galatolo M, Tortelli A, Tagliabue I, Turco M, Pompili M, Selten JP, de Haan L, Rossi Menezes P, Del Ben CM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, O'Donovan M, Rutten BP, Van Os J, Morgan C, Sham PC, Austin-Zimmerman I, Li Z, Vassos E; EU-GEI WP2 Group; Murray RM, Di Forti M. Spinazzola E, et al. Psychol Med. 2023 Nov;53(15):7418-7427. doi: 10.1017/S0033291723001071. Epub 2023 May 2. Psychol Med. 2023. PMID: 37129249 Free PMC article.
  • The genomic psychiatry cohort: partners in discovery.
    Pato MT, Sobell JL, Medeiros H, Abbott C, Sklar BM, Buckley PF, Bromet EJ, Escamilla MA, Fanous AH, Lehrer DS, Macciardi F, Malaspina D, McCarroll SA, Marder SR, Moran J, Morley CP, Nicolini H, Perkins DO, Purcell SM, Rapaport MH, Sklar P, Smoller JW, Knowles JA; Genomic Psychiatry Cohort Consortium; Pato CN. Pato MT, et al. Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):306-12. doi: 10.1002/ajmg.b.32160. Epub 2013 May 3. Am J Med Genet B Neuropsychiatr Genet. 2013. PMID: 23650244 Free PMC article.
  • Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?
    Jansson LB, Parnas J. Jansson LB, et al. Schizophr Bull. 2007 Sep;33(5):1178-200. doi: 10.1093/schbul/sbl065. Epub 2006 Dec 8. Schizophr Bull. 2007. PMID: 17158508 Free PMC article. Review.

LinkOut - more resources